Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Amino acid deficiency and the skin rash associated with glucagonoma.

Norton JA, Kahn CR, Schiebinger R, Gorschboth C, Brennan MF.

Ann Intern Med. 1979 Aug;91(2):213-5.

PMID:
111595
2.

Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome.

Alexander EK, Robinson M, Staniec M, Dluhy RG.

Clin Endocrinol (Oxf). 2002 Dec;57(6):827-31.

PMID:
12460334
3.

Rapid resolution of necrolytic migratory erythema after glucagonoma resection.

Smith AP, Doolas A, Staren ED.

J Surg Oncol. 1996 Apr;61(4):306-9.

PMID:
8628004
4.

Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.

Katz R, Fischmann AB, Galotto J, Guccio JG, Higgins GA, Ortega LG, West WH, Recant L.

Cancer. 1979 Aug;44(2):558-63.

5.

Effect of somatostatin on skin lesions and concentrations of plasma amino acids in a patient with glucagonoma-syndrome.

Schmid R, Allescher HD, Schepp W, Hölscher A, Siewert R, Schusdziarra V, Classen M.

Hepatogastroenterology. 1988 Feb;35(1):34-7.

PMID:
2896149
6.

Disappearance of glucagonoma rash after surgical resection, but not during dietary normalization of serum amino acids.

Abraira C, DeBartolo M, Katzen R, Lawrence AM.

Am J Clin Nutr. 1984 Mar;39(3):351-5.

PMID:
6320631
7.

[Necrolytic migratory erythema revealing glucagonoma without diabetes].

Marty C, Bennet A, Bayle P, Danjoux M, Lalande T, Marguery MC, Bazex J.

Ann Med Interne (Paris). 2003 Dec;154(8):552-6. French.

PMID:
15037834
8.

Malignant glucagonoma syndrome: response to chemotherapy.

Marynick SP, Fagadau WR, Duncan LA.

Ann Intern Med. 1980 Sep;93(3):453-4.

PMID:
6254416
9.

A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.

Fujita J, Seino Y, Ishida H, Taminato T, Matsukura S, Horio T, Imamura S, Naito A, Tobe T, Takahashi K, et al.

Cancer. 1986 Feb 15;57(4):860-5.

10.

[Necrolytic migratory erythema in Waldmann's disease].

Baricault S, Soubrane JC, Courville P, Young P, Joly P.

Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):693-6. French.

PMID:
17053741
11.
12.

The glucagonoma syndrome in a Chinese man.

Lee KO, Chan HL, Lee HL.

Ann Acad Med Singapore. 1985 Apr;14(2):312-6.

PMID:
2994543
13.

Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).

Skouge JW, Farmer ER.

Arch Dermatol. 1985 Mar;121(3):400, 403. No abstract available.

PMID:
2983618
14.

Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.

Du Jardin P, Cools P, Van der Stighelen Y.

Acta Chir Belg. 2004 Aug;104(4):468-70.

PMID:
15469167
15.

Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema.

Bewley AP, Ross JS, Bunker CB, Staughton RC.

Br J Dermatol. 1996 Jun;134(6):1101-4.

PMID:
8763433
16.

[Necrolytic migratory erythema].

Dandrifosse JF, Dandrifosse AC, Piérard G, Scheen AJ, Dandrifosse G.

Rev Med Liege. 1998 Dec;53(12):778-83. French.

PMID:
9927878
17.

Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.

Peterson LL, Shaw JC, Acott KM, Mueggler PA, Parker F.

J Am Acad Dermatol. 1984 Sep;11(3):468-73.

PMID:
6090515
18.

Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration.

Santangelo WC, Unger RH, Orci L, Dueno MI, Popma JJ, Krejs GJ.

Pancreas. 1986;1(5):464-9.

PMID:
2882503
19.

Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome.

Kahan RS, Perez-Figaredo RA, Neimanis A.

Arch Dermatol. 1977 Jun;113(6):792-7.

PMID:
194537
20.

Effect of somatostatin in necrolytic migratory erythema of glucagonoma.

Elsborg L, Glenthøj A.

Acta Med Scand. 1985;218(2):245-9.

PMID:
2865872

Supplemental Content

Support Center